Business Wire

Kymeta and e3 Systems Reveal First Superyacht Sea Trials with Motor Yacht Prior to Monaco Yacht Show

Del

Redmond, Washington-based Kymeta, and exclusive superyacht distribution partner, e3 Systems, today revealed that the White Rose of Drachs has been performing the first-ever motor yacht sea trials with Kymeta communications solutions over the last several months with successful results. Up-close views of the trial installation of Kymeta KyWay™ terminals on the yacht will be available at the Monaco Yacht Show September 27-30, 2017.

Kymeta and e3 Systems worked with the owner, captain, and IT manager of the White Rose to perform the months-long sea trial, and outfitted the yacht with four Kymeta KyWay terminals. The terminals were tested with various MIR/CIR services from leading maritime satellite service providers, including Speedcast, which provided service in the Mediterranean. Upon completion of sea trials and commercial release of yacht solutions, Kymeta terminals will be bundled with Kymeta’s KĀLO™ internet access services - powered by the IntelsatOne Flex for Maritime service. The terminals can also be outfitted with MIR/CIR services from service providers like Speedcast.

“We trialed multiple terminal configurations, ranging from single panel solutions to multiple panel solutions. We experienced a few practical installation issues, many of which already have been addressed by Kymeta, and we also realized that the network systems on yachts need to be designed and configured to work in tandem with the improved throughput that Kymeta solutions provide,” said Roger Horner, Managing Director at e3 Systems. “The flat panel beam steering of the antenna and its performance has been fantastic, and we are pleased that the issues found and communicated are already being addressed. Identifying and solving issues is what sea trialing is all about.”

The trials presented Kymeta and e3 engineers with the opportunity to identify and replace various components – both hardware and software. As a software defined antenna technology, Kymeta KyWay terminals used at the trial were given improved and added functionality, remotely, which has never been possible before with traditional mechanically steered antennas.

“The months-long sea trials with the White Rose have provided our engineering team with valuable insights for maritime installations. While we experienced some challenges during the trials, it wasn’t anything we couldn’t overcome, and it is now clear that domeless vessels are a new reality for the yacht industry,” said Håkan Olsson, Vice President of Maritime at Kymeta. “This is a major milestone for the maritime industry, where reliable, flat, lightweight satellite connectivity will open an entirely new world of communication capabilities.”

The trialing period also afforded Andrew Schofield, captain of the White Rose, to witness firsthand the ease with which Kymeta communication solutions can be updated and managed – even while at sea. “One day while testing the Kymeta solutions at sea, the e3 Systems and Kymeta teams removed terminals, changed components, and reinstalled them within minutes,” said Schofield. “With conventional antennas, we would have been in the yard for a few days with a crane to achieve the same results. The quick installation of the Kymeta solution is a big time and money-saver.”

Schofield recognizes other benefits in addition to saved time and manpower. “We have been anticipating Kymeta technology since 2015 when we first saw conceptual animations of the technology,” said Schofield. “We are proud to be the first motor yacht to perform sea trials with Kymeta technology. We look forward to progressing from the current temporary trial installation to the finalized fully-integrated solution, which will rid the yacht of the current VSAT and TVRO domes. This will remove over five tons of weight from her super structure and provide the yacht with permanent access to the internet.”

About Kymeta
What’s the missing link to connecting billions of people to high-speed mobile access? Antennas. And Kymeta offers the world’s only commercially-viable electronically-scanning satellite antennas and terminals. Kymeta antennas and terminals deliver high-throughput communications for land, sea, and air, making mobile connectivity as available as a view of the sky. Plus, the world’s largest satellite operator, Intelsat, has joined forces with Kymeta to deliver KĀLO global access services that combine with Kymeta antennas and terminals to provide revolutionary mobile connectivity. Without Kymeta mTenna™ technology, connecting and staying connected to all those new satellites while on the move will be difficult, if not impossible.

If it moves, Kymeta will keep it connected. Anywhere.

For more information, visit kymetacorp.com and KALO.net.

About e3 Systems
e3 Systems® is a leading communications integrator and solutions provider for the marine industry. The company connects yachts globally through a diverse portfolio of communication systems including its HYBRID solution which synchronises VSAT, Inmarsat, Iridium, 3G, 4G and Wi-Fi.

In addition, e3 provides an extensive suite of services covering cyber security and training, comprehensive IT support, data management through the Advanced Monitoring and Management System e3.ARMMS, and content provision including TV and internet.

e3 operates from the Mediterranean and the USA with thirty partners worldwide. It is part of the marine electronics group grupoarbulu.

Contact information

Business Inquiries for Kymeta:
Kymeta Corporation
Lisa Dreher, +1 425-658-8724
Director of Marketing
ldreher@kymetacorp.com
or
Media Inquiries for Kymeta:
The Summit Group
Amy Oliver, +1 801-990-1185
PR/Content Manager
aoliver@summitslc.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life19.11.2017 16:31Pressemelding

Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of Cancer Patients (FoCP), a non-profit organisation that supports cancer patients and their families. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005048/en/ During MENA's first Global Relay For Life walkathon - Source: Friends of Cancer Patients Taking place November 17-18 at the American University Sharjah, the inaugural UAE RFL saw more than 2,000 relayers participating in the overnight event, with a large number of individuals and institutions involved including 52 sch

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00Pressemelding

AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20Pressemelding

AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute

Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11Pressemelding

The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other

Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 16:20Pressemelding

Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to

Ncardia Announces Completion of €10.5M Investment Round17.11.2017 12:31Pressemelding

Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom